GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Baskhanbiopharma Inc (XKRX:354390) » Definitions » Tax Provision

Baskhanbiopharma (XKRX:354390) Tax Provision : ₩27 Mil (TTM As of Dec. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Baskhanbiopharma Tax Provision?

Baskhanbiopharma's tax provision for the six months ended in Dec. 2024 was ₩27 Mil. Its tax provision for the trailing twelve months (TTM) ended in Dec. 2024 was ₩27 Mil.


Baskhanbiopharma Tax Provision Historical Data

The historical data trend for Baskhanbiopharma's Tax Provision can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Baskhanbiopharma Tax Provision Chart

Baskhanbiopharma Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Tax Provision
440.00 - - 1,515.76 26.63

Baskhanbiopharma Semi-Annual Data
Dec20 Dec21 Dec22 Dec23 Dec24
Tax Provision 440.00 - - 1,515.76 26.63

Baskhanbiopharma Tax Provision Calculation

Tax to be paid.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Tax Provision for the trailing twelve months (TTM) ended in Dec. 2024 was ₩27 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Baskhanbiopharma Business Description

Traded in Other Exchanges
N/A
Address
354 Wondang-ro, Wongok-myeon, Anseong-si, Gyeonggi-do, KOR
Baskhanbiopharma Inc manufactures and distributes prescription drugs, over the counter drugs, medical devices and other related products.

Baskhanbiopharma Headlines

No Headlines